Why the study?
Transthoracic low-frequency ultrasound was shown to cause canine coronary vasodilation, prompting evaluation of the potential vasodilator effects of transcutaneous low-frequency ultrasound in human brachial arteries.
Does transcutaneous low-frequency ultrasound cause vasodilation in human brachial arteries?
Does transcutaneous low-frequency ultrasound cause vasodilation in human brachial arteries?
Transcutaneous low-frequency ultrasound induces rapid, significant vasodilation in human brachial arteries, suggesting potential diagnostic and therapeutic applications for vascular disease.
No role in current clinical practice; leaves open therapeutic potential of low-frequency ultrasound in coronary disease.
OBJECTIVES: We evaluated the potential vasodilator effects of transcutaneous low-frequency ultrasound (US) in human brachial arteries. BACKGROUND: Recent data show that transthoracic low-frequency US energy results in canine coronary artery vasodilation. METHODS: Brachial artery diameters were measured before and after low-frequency US (29 kHz, 1.4 W/cm2) exposure using US imaging with a linear-array transducer. We assessed the time course of diameter changes after US in 20 subjects. In 10 of 20 subjects, brachial artery flow-mediated vasodilation (FMD) was measured to compare the effect of US to a standard method of evaluating endothelial function. RESULTS: Significant vasodilation was seen after 2 min of US compared with baseline values. At 5 min of US, the brachial artery diameter increased by 4.1%. In addition, the arteries continued to dilate after US exposure. At 3 min after US there was a 5.4%, and at 5 min after US a 6.0% increase in vessel diameter (p < 0.001). These diameters returned to baseline dimensions about 20 min after stopping US. Ultrasound-mediated vasodilation and percentage FMD showed good correlation (r = 0.87; p < 0.001). CONCLUSIONS: This is the first study to demonstrate that noninvasive transcutaneous low-frequency US energy dilates human brachial arteries. This arterial vasodilator effect has a rapid onset (within 2 min), lasts about 20 min, and is similar in magnitude to that of FMD. The vasodilator effect of US may have diagnostic and therapeutic potential in patients with or at risk for vascular disease.
No takes yet. Share an insight, caveat, or question.
Iida et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: